Skip to content
Review

Prevalence of polypharmacy and potentially inappropriate medication use among older adults receiving home health care: a systematic review and meta-analysis

2026 · International Journal of Medicine in Developing Countries · 0 citations

Abstract

Home health care serves some of the oldest, most multimorbid community-dwelling adults, but the burden of polypharmacy and potentially inappropriate medication (PIM) use in this population has not been systematically quantified. This study aimed to estimate this prevalence and summarize associated determinants and clinical outcomes. PubMed/MEDLINE, Europe PMC, and OpenAlex were searched systematically up to 16 September 2026, with grey-literature searching, following a protocol registered on PROSPERO (CRD420261495874). Observational studies and randomized-trial baseline data reporting polypharmacy or PIM use prevalence in home-care recipients aged 65 years or older were eligible. Two reviewers independently screened and extracted data, with adjudication; risk of bias was assessed with the Joanna Briggs Institute prevalence checklist. Proportions were pooled with random-effects DerSimonian-Laird models. Of 1,043 records identified, 57 studies (2000-2026) met inclusion criteria, and 30 contributed 34 prevalence estimated to the primary analyses. Pooled PIM-use prevalence was 40.6% (95% confidence interval [CI] 36.0-45.3; 22 studies). Pooled polypharmacy prevalence was 66.1% (95% CI 43.2-83.4; 12 studies), with extreme heterogeneity (I-squared ≥ 99.5%). PIM prevalence was highest in Asia, lowest in North America, and rose across publication decades. Polypharmacy was the most consistent determinant of PIM use; in one US Medicare cohort, PIM use was associated with hospitalization (relative risk 1.13, 95% CI 1.09-1.17). About two in five old home-care recipients use at least one PIM and two in three meet a study-defined polypharmacy threshold, with wide between-study heterogeneity and low certainty. Structured medication review, built into home-care episodes, is a priority for this high-risk, understudied population.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.